Experts outline what it takes to build a sustainable CGT program, from governance and SOPs to navigating complex reimbursement landscapes.
Elias Pittos, PharmD
Advertisement
Elias Pittos, PharmD, BCOP, CSP, is the medical director of cell, gene, and advanced therapies at McKesson in Chicago.
Articles by Elias Pittos, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV
2
New Bill Would Cap Traditional Medicare Out-of-Pocket Costs at $5000
3
Topical Delgocitinib Improves Chronic Hand Eczema Outcomes Across All Trial Timepoints
4
COA Offers Playbook to Help Community Oncology Practices Navigate AI Partnerships
5